Management of subsolid pulmonary nodules in CT lung cancer screening

Journal of Thoracic Disease

Volumn 7, Issue 7, 2015, Pages 1103-1106

  Heuvelmans, Marjolein A ^a   Oudkerk, Matthijs ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Computed topography; Lung cancer; Screening; Subsolid pulmonary nodule (SSN)

Indexed keywords

CANCER CLASSIFICATION; CANCER SCREENING; CANCER STAGING; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EDITORIAL; FOLLOW UP; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NODULE; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PROBABILITY; SUBSOLID PULMONARY NODULE;

EID: 84939645642     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2015.07.23     Document Type: Editorial

References (25)

1. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
2. Detterbeck FC, Mazzone PJ, Naidich DP, et al. Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidencebased clinical practice guidelines. Chest 2013;143:e78S-92S.
3. Wender R, Fontham ET, Barrera E Jr, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107-17.
4. Humphrey LL, Deffebach M, Pappas M, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med 2013;159:411-20.
5. American Lung Association Lung Cancer Screening Committee. Providing Guidance on Lung Cancer Screening to Patients and Physicians. 2012. Available online: http://www.lung.org/lung-disease/lung-cancer/lung-cancerscreening-guidelines/lung-cancer-screening.pdf.
6. Moyer VA. Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2014;160:330-8.
7. American College of Radiology. Lung CT Screening Reporting and Data System (Lung-RADS). Available online: http://www.acr.org/Quality-Safety/Resources/LungRADS.
8. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-9.
9. Veronesi G, Bellomi M, Mulshine JL, et al. Lung cancer screening with low-dose computed tomography: a noninvasive diagnostic protocol for baseline lung nodules. Lung Cancer 2008;61:340-9.
10. Naidich DP, Bankier AA, MacMahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013;266:304-17.
11. Suzuki K, Asamura H, Kusumoto M, et al. "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 2002;74:1635-9.
12. Aoki T, Nakata H, Watanabe H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol 2000;174:763-8.
13. Vazquez M, Carter D, Brambilla E, et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 2009;64:148-54.
14. Oh JY, Kwon SY, Yoon HI, et al. Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT. Lung Cancer 2007;55:67-73.
15. Park CM, Goo JM, Lee HJ, et al. Nodular groundglass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up. Radiographics 2007;27:391-408.
16. de Hoop B, Gietema H, van de Vorst S, et al. Pulmonary ground-glass nodules: increase in mass as an early indicator of growth. Radiology 2010;255:199-206.
17. Nakata M, Saeki H, Takata I, et al. Focal groundglass opacity detected by low-dose helical CT. Chest 2002;121:1464-7.
18. Park CM, Goo JM, Kim TJ, et al. Pulmonary nodular ground-glass opacities in patients with extrapulmonary cancers: what is their clinical significance and how can we determine whether they are malignant or benign lesions? Chest 2008;133:1402-9.
19. Lee HJ, Goo JM, Lee CH, et al. Predictive CT findings of malignancy in ground-glass nodules on thin-section chest CT: the effects on radiologist performance. Eur Radiol 2009;19:552-60.
20. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000;73:1252-9.
21. Infante M, Berghmans T, Heuvelmans MA, et al. Slowgrowing lung cancer as an emerging entity: from screening to clinical management. Eur Respir J 2013;42:1706-22.
22. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Lung Cancer Screening. 2013.
23. Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e93S-120S.
24. Scholten ET, de Jong PA, de Hoop B, et al. Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules? Eur Respir J 2015;45:765-73.
25. Yankelevitz DF, Yip R, Smith JP, et al. CT Screening for Lung Cancer: Nonsolid Nodules in Baseline and Annual Repeat Rounds. Radiology 2015:142554. [Epub ahead of print].